Skip to Main Content

Paper Details

Non-inferiority in cancer clinical trials was associated with more lenient margins and higher hypothesized outcome event rates.
J Clin Epidemiol
1
2021
Author NameAffiliation
Xia ShenSun Yat-sen University, PR China Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University
  • 1 - 1

Datasets